Aster DM Keeps 'Buy' From HSBC On Plans To Sell Gulf Business
Aster DM Healthcare Ltd. may improve its stock performance if the company sells its Gulf business, according to HSBC Global Research.
The gulf business would turn over good profit in the company's balance sheet should the sale happen, the brokerage said in a note on Tuesday. In the event of a sale, the board will also return some part of the profits to the shareholders, according to its management.
Aster DM has been looking to sell its Gulf Cooperation Council countries business for over a year. The company's group Chief Financial Officer, Sreenath Pocha Reddy, had resigned earlier this year.
HSBC has maintained a 'buy' on the stock, with a price target of Rs 330 per share, implying an upside potential of about 17.8% from Monday's close.
HSBC Global On Aster DM Healthcare
Maintains a 'buy' rating, with a price target of Rs 330 apiece.
The company is discussing the sale of its Gulf business, which includes several Saudi hospitals, and binding bids are expected soon.
Aster's share price has increased as investors have started factoring in the probable sale of the GCC business and the improved valuation of healthcare sector in general.
The brokerage said that Aster's loss increased in the second quarter of 2023 due to the addition of a low-return hospital in Muscat.
However, revenue growth improved in the last quarter of 2023 on the signing of a new operations and management agreement in Kerala, and the opening of new hospitals in Tirupati and Vijayawada.
Despite a year-on-year revenue growth of 16% in fiscal 2023, Aster's operating profit fell 7% year-on-year, due to loss from the new hospitals.
The company's announcement of the development of a 150-bed facility in the Grand Cayman Island for medical patients in the Americas is a poor investment, according to HSBC.
Key risks are the pending restructuring of the company, capital allocation and the complexity of modelling within the healthcare company.
Shares of Aster DM Healthcare rose 14.55% to reach a record high of Rs 328.70 apiece, compared to a 0.49% uptick in the benchmark Nifty 50.
Of the nine analysts tracking the company, eight maintain a 'buy' rating and one recommends a 'hold', according to Bloomberg data. The average 12-month price target implies a downside of 2.9%.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.